Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Chronic Heart Failure

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 327 articles: HTML format

Single Articles

April 2023
1. FERREIRA JP, Cleland JG, Girerd N, Rossignol P, et al
   Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.
   Int J Cardiol. 2023;377:86-88.
   PubMed     Abstract available
   
   
   
2. CHRISTOPH M, Marius S, Karl S, Friedrich K, et al
   Efficacy of CRT upgrade in pacemaker-induced cardiomyopathy in an outpatient clinic - Results of a prospective registry.
   Int J Cardiol. 2023;377:60-65.
   PubMed     Abstract available
   
   
   
3. YANG Q, Wu H, Liu D, Li Y, et al
   Discussion of a study on the role of EMS in prognosis of elderly patients with AHF.
   Int J Cardiol. 2023;377:91.
   PubMed    
   
   
   March 2023
4. ZHANG HD, Yan Y, He YY, Liu QQ, et al
   Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease.
   Int J Cardiol. 2023;375:29-35.
   PubMed     Abstract available
   
   
   
5. LI X, Shen Y, Xu X, Guo G, et al
   Genomic and RNA-Seq profiling of patients with HFrEF unraveled OAS1 mutation and aggressive expression.
   Int J Cardiol. 2023;375:44-54.
   PubMed     Abstract available
   
   
   
6. FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
   Prognostic implications of six-minute walking distance in patients with heart failure with preserved ejection fraction.
   Int J Cardiol. 2023 Mar 11:S0167-5273(23)00396.
   PubMed     Abstract available
   
   
   
7. BURGER PM, Koudstaal S, Dorresteijn JAN, Savarese G, et al
   Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease.
   Int J Cardiol. 2023 Mar 11:S0167-5273(23)00395.
   PubMed     Abstract available
   
   
   
8. HEEGAARD B, Deis T, Rossing K, Ersboll M, et al
   Diabetes mellitus and hemodynamics in advanced heart failure.
   Int J Cardiol. 2023 Mar 10:S0167-5273(23)00341.
   PubMed     Abstract available
   
   
   
9. KAWAJI T, Shiomi H, Bao B, Hojo S, et al
   Intracardiac energy inefficiency during atrial fibrillation rhythm with heart failure: Assessment by echo-vector flow mapping.
   Int J Cardiol. 2023 Mar 10:S0167-5273(23)00392.
   PubMed     Abstract available
   
   
   
10. DURAN A, Ventura HO
    The value of frequent objective risk assessments in heart failure management.
    Int J Cardiol. 2023 Mar 6:S0167-5273(23)00333.
    PubMed    
    
    
    
11. MOHEBI R, Liu Y, Murphy SP, Gaggin HK, et al
    Clinical profiling of end-stage heart failure with preserved ejection fraction: The National Readmission Database.
    Int J Cardiol. 2023 Mar 2:S0167-5273(23)00269.
    PubMed     Abstract available
    
    
    
12. ZAMPIERI M, Salvi S, Fumagalli C, Argiro A, et al
    Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation.
    Int J Cardiol. 2023;374:65-72.
    PubMed     Abstract available
    
    
    
13. LIU Y, Li Y, Zhang J, Zhao Y, et al
    Pregnancy outcomes of women with Eisenmenger syndrome: A single-center study.
    Int J Cardiol. 2023;374:35-41.
    PubMed     Abstract available
    
    
    February 2023
14. DIEZ MPL, Alquezar-Arbe A, Jacob J, Llorens P, et al
    Hospital development of heart failure follow-up units and short-term prognosis after acute decompensation in Spain.
    Int J Cardiol. 2023 Feb 17:S0167-5273(23)00247.
    PubMed     Abstract available
    
    
    
15. SEFEROVIC PM, Polovina M, Seferovic J, Rosano G, et al
    Corrigendum to "Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes" [International Journal of Cardiology 2023 Jan 15;371:293-294 10.1016/j.ijcard.2022.09.019.
    Int J Cardiol. 2023 Feb 16:S0167-5273(23)00232.
    PubMed    
    
    
    
16. XING C, Wang X, Pan X, Yu J, et al
    Outcomes of atrial septostomy and effect on long-term survival in patients with idiopathic pulmonary arterial hypertension: A single-center cohort.
    Int J Cardiol. 2023;373:118-123.
    PubMed     Abstract available
    
    
    
17. SHIROTANI S, Jujo K, Takada T, Abe T, et al
    Renin-angiotensin system inhibitor exerts prognostic effects in HFpEF patients with low baseline chloride level.
    Int J Cardiol. 2023;373:83-89.
    PubMed     Abstract available
    
    
    
18. NISHINO M, Egami Y, Kawanami S, Sugae H, et al
    Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00237.
    PubMed     Abstract available
    
    
    
19. KERSTENS TP, Weerts J, van Dijk APJ, Weijers G, et al
    Left ventricular strain-volume loops and diastolic dysfunction in suspected heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00167.
    PubMed     Abstract available
    
    
    
20. YANAGISAWA S, Inden Y, Murohara T
    Catheter ablation for atrial fibrillation in heart failure: Getting closer to the full picture in the whole population.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00226.
    PubMed    
    
    
    
21. GOES-SANTOS BR, Rondon E, Fonseca GWP, Sales ARK, et al
    Physical capacity increase in patients with heart failure is associated with improvement in muscle sympathetic nerve activity.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00234.
    PubMed     Abstract available
    
    
    
22. CAMPBELL-QUINTERO S, Echeverria LE, Gomez-Mesa JE, Rivera-Toquica A, et al
    Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00236.
    PubMed     Abstract available
    
    
    
23. KOSTANJSEK L, Ardissino M, Moussa O, Rayes B, et al
    Effect of bariatric surgery on the incidence of heart failure: A propensity score matched nationwide cohort study.
    Int J Cardiol. 2023 Feb 2:S0167-5273(23)00169.
    PubMed     Abstract available
    
    
    January 2023
24. NGUYEN BN, Mital S, Bugden S, Nguyen HV, et al
    Cost-effectiveness of dapagliflozin and empagliflozin for treatment of heart failure with reduced ejection fraction.
    Int J Cardiol. 2023 Jan 31:S0167-5273(23)00120.
    PubMed     Abstract available
    
    
    
25. PEZZUTO B, Piepoli M, Galotta A, Sciomer S, et al
    The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database.
    Int J Cardiol. 2023 Jan 27:S0167-5273(23)00110.
    PubMed     Abstract available
    
    
    
26. WERNHART S, Papathanasiou M, Rassaf T, Luedike P, et al
    Heart failure classification based on resting ejection fraction does not display a unique exercise response pattern.
    Int J Cardiol. 2023 Jan 27:S0167-5273(23)00113.
    PubMed     Abstract available
    
    
    
27. CASULA M, Pignalosa L, Quilico F, Scajola LV, et al
    A comprehensive meta-analysis comparing radiofrequency ablation versus pharmacological therapy for the treatment of atrial fibrillation in patients with heart failure.
    Int J Cardiol. 2023 Jan 26:S0167-5273(23)00111.
    PubMed     Abstract available
    
    
    
28. CANEPA M, Leporatti L, Persico L, Ameri P, et al
    Corrigendum to "Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy" [Int J Cardiol. 2022 Sep 15;363:111-118].
    Int J Cardiol. 2023 Jan 20:S0167-5273(23)00057.
    PubMed    
    
    
    
29. KONG G, Chin YH, Chong B, Goh RSJ, et al
    Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients.
    Int J Cardiol. 2023;371:432-440.
    PubMed     Abstract available
    
    
    
30. KIRSCH M, Feriel M, Aurelia LT, Oksana K, et al
    Impact of training on combined cardiopulmonary exercise test with stress echocardiography parameters in HFrEF patients.
    Int J Cardiol. 2023;371:252-258.
    PubMed     Abstract available
    
    
    
31. TOTO F, Salvioni E, Magri D, Sciomer S, et al
    Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base.
    Int J Cardiol. 2023;371:273-277.
    PubMed     Abstract available
    
    
    
32. LIANG J, Zhang Z
    Predictors of in-hospital heart failure in patients with acute anterior wall ST-segment elevation myocardial infarction.
    Int J Cardiol. 2023 Jan 10:S0167-5273(23)00043.
    PubMed     Abstract available
    
    
    
33. MIYAMOTO R, Nagao K, Matsuto K, Hata R, et al
    Relationship between atrial fibrillation and a liver fibrogenesis marker in patients with acute heart failure.
    Int J Cardiol. 2023 Jan 10:S0167-5273(23)00001.
    PubMed     Abstract available
    
    
    
34. IWAHASHI N
    Right ventricular strain and mechanical dispersion for heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Jan 5:S0167-5273(22)01977.
    PubMed    
    
    
    
35. MATSUTO K, Maruichi-Kawakami S, Aida K, Imamoto K, et al
    Prognostic implications of post-discharge hemodynamic congestion assessed by peripheral venous pressure among patients discharged from acute heart failure.
    Int J Cardiol. 2023 Jan 4:S0167-5273(22)01982.
    PubMed     Abstract available
    
    
    
36. GALASSI A, Cara A, Magagnoli L, Faccioli FM, et al
    Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concerns.
    Int J Cardiol. 2023;370:321-322.
    PubMed    
    
    
    
37. TROMBARA F, Alimento ML
    Should we be afraid of moderate hyperkalemia in HFrEF outpatients?
    Int J Cardiol. 2023;370:323-324.
    PubMed    
    
    
    
38. ZANNONI J, Guazzi M, Milani V, Bandera F, et al
    Prognostic value of cardiopulmonary exercise testing in a European cohort with cardiovascular risk factors absent of a cardiovascular disease diagnosis.
    Int J Cardiol. 2023;370:402-404.
    PubMed     Abstract available
    
    
    
39. LUND LH, Zeymer U, Clark AL, Barrios V, et al
    Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry.
    Int J Cardiol. 2023;370:279-286.
    PubMed     Abstract available
    
    
    December 2022
40. KOBAYASHI M, Ferreira JP, Matsue Y, Chikamori T, et al
    Effect of eplerenone on clinical stability of Japanese patients with acute heart failure.
    Int J Cardiol. 2022 Dec 28:S0167-5273(22)01938.
    PubMed     Abstract available
    
    
    
41. KURASHIMA S, Kitai T, Matsue Y, Nogi K, et al
    Trajectory of serum chloride levels during decongestive therapy in acute heart failure.
    Int J Cardiol. 2022 Dec 27:S0167-5273(22)01933.
    PubMed     Abstract available
    
    
    
42. AMPARO TAVERAS H
    The dilemma of thromboembolism prophylaxis in patient with acute heart failure.
    Int J Cardiol. 2022 Dec 16:S0167-5273(22)01913.
    PubMed    
    
    
    
43. JUG B
    Heart failure with reduced ejection fraction and low blood pressure: Overcoming another barrier to guideline-directed medical therapy?
    Int J Cardiol. 2022 Dec 8:S0167-5273(22)01882.
    PubMed    
    
    
    
44. KAUR G, Jones M, Howes L, Hattingh HL, et al
    Systematic review and meta-analysis of the association between all-cause mortality and statin therapy in patients with preserved ejection fraction heart failure (HFpEF).
    Int J Cardiol. 2022 Dec 7:S0167-5273(22)01871.
    PubMed     Abstract available
    
    
    
45. WEWER ALBRECHTSEN NJ, Bojsen-Moller KN
    Letter to the Editor regarding to 'Activation of GLP-1 receptor signalling by sacubitril/valsartan: Implications for patients with poor glycaemic control'.
    Int J Cardiol. 2022;368:55.
    PubMed    
    
    
    November 2022
46. SEPHIEN A, Ghobrial M, Reljic T, Prida X, et al
    Efficacy of SGLT2 inhibitors in patients with heart failure: An overview of systematic reviews.
    Int J Cardiol. 2022 Nov 28:S0167-5273(22)01739.
    PubMed     Abstract available
    
    
    
47. VAN BERGEIJK KH, Wykrzykowska JJ, Sartori S, Snyder C, et al
    Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.
    Int J Cardiol. 2022 Nov 28:S0167-5273(22)01743.
    PubMed     Abstract available
    
    
    
48. KANG Y, Hwang HY
    Carbohydrate antigen 125; A biomarker not only for medical patients but also for surgical patients with heart failure.
    Int J Cardiol. 2022 Nov 26:S0167-5273(22)01733.
    PubMed    
    
    
    
49. DU Y, Yuan N, Yan J, Han G, et al
    Identification of echocardiographic subgroups in patients with coronary heart disease combined with heart failure based on latent variable stratification.
    Int J Cardiol. 2022 Nov 25:S0167-5273(22)01725.
    PubMed     Abstract available
    
    
    
50. MAHTANI K, Patel B, Wang B, Barron A, et al
    Activation of GLP-1 receptor signalling by sacubitril/valsartan: Implications for patients with poor glycaemic control.
    Int J Cardiol. 2022;367:81-89.
    PubMed     Abstract available
    
    
    
51. HAMATANI Y, Kato T, Morimoto T, Iguchi M, et al
    Association of intravenous heparin administration with in-hospital clinical outcomes among hospitalized patients with acute heart failure.
    Int J Cardiol. 2022 Nov 11. pii: S0167-5273(22)01705.
    PubMed     Abstract available
    
    
    
52. CAI J, Zhang L, Chen C, Ge J, et al
    Association between serum klotho concentration and heart failure in adults, a cross-sectional study from NHANES 2007-2016.
    Int J Cardiol. 2022 Nov 6. pii: S0167-5273(22)01697.
    PubMed     Abstract available
    
    
    
53. PASQUALIN G, Chessa M
    HFpEF, HFmEF, HFrEF in adults with congenital heart disease: Time to face it.
    Int J Cardiol. 2022;366:19.
    PubMed    
    
    
    
54. GOMEZ-HOSPITAL JA, Ferreiro JL
    Percutaneous circulatory support in high-risk PCI: Pulsatile or continuous flow devices?
    Int J Cardiol. 2022;366:80-81.
    PubMed    
    
    
    October 2022
55. SHANAH L, Mir T, Uddin MM, Hussain T, et al
    Clinical outcomes and 30-day readmissions for heart failure with reduced ejection fraction with cardiorenal syndrome: A National Cohort Study.
    Int J Cardiol. 2022 Oct 31. pii: S0167-5273(22)01672.
    PubMed     Abstract available
    
    
    
56. DE FILIPPO O, D'Ascenzo F, Wojciech W, Leonardi S, et al
    IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.
    Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01658.
    PubMed     Abstract available
    
    
    
57. FAABORG-ANDERSEN CC, daSilva-deAbreu A, Ventura HO
    Optimized dosing of guideline-directed medical therapies is essential in heart failure with reduced ejection fraction.
    Int J Cardiol. 2022 Oct 20. pii: S0167-5273(22)01648.
    PubMed    
    
    
    
58. BEREZIN AE
    Heart failure with recovered ejection fraction: The role of HbA1c level in hospitalized heart failure patients with type 2 diabetes.
    Int J Cardiol. 2022 Oct 19. pii: S0167-5273(22)01531.
    PubMed    
    
    
    
59. KANEKO T, Kagiyama N, Nakamura Y, Dotare T, et al
    External validation of the ACUTE HF score for risk stratification in acute heart failure.
    Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01641.
    PubMed     Abstract available
    
    
    
60. KISHIHARA M, Takada T, Jujo K, Shirotani S, et al
    Prognostic impact of guideline-directed medical therapy in patients with heart failure on regular hemodialysis.
    Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01642.
    PubMed     Abstract available
    
    
    
61. IZUMI K, Kohno T, Goda A, Takeuchi S, et al
    Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01640.
    PubMed     Abstract available
    
    
    
62. TAKEUCHI S, Kohno T, Goda A, Shiraishi Y, et al
    Malnutrition in real-world patients hospitalized for heart failure with preserved ejection fraction and its potential impact on generalizability of EMPEROR-Preserved trial.
    Int J Cardiol. 2022 Oct 15. pii: S0167-5273(22)01533.
    PubMed     Abstract available
    
    
    
63. PROFF J, Merkely B, Papp R, Lenz C, et al
    Closed loop stimulation in patients with chronic heart failure and severe chronotropic incompetence: Responders versus non-responders.
    Int J Cardiol. 2022 Oct 12. pii: S0167-5273(22)01530.
    PubMed     Abstract available
    
    
    
64. SIMON W, Maria P, Mahabadi AA, Tienush R, et al
    Betablockers reduce oxygen pulse increase and performance in heart failure patients with preserved ejection fraction.
    Int J Cardiol. 2022 Oct 8. pii: S0167-5273(22)01478.
    PubMed     Abstract available
    
    
    
65. CHEN A, Geng Z, Zhang Y
    Efficacy and safety of early cardiac rehabilitation for patients with heart failure.
    Int J Cardiol. 2022 Oct 5. pii: S0167-5273(22)01471.
    PubMed    
    
    
    
66. CASTRO-PORTILLO E, Lopez-Izquierdo R, Sanz-Garcia A, Ortega GJ, et al
    Role of prehospital point-of-care N-terminal pro-brain natriuretic peptide in acute life-threatening cardiovascular disease.
    Int J Cardiol. 2022;364:126-132.
    PubMed     Abstract available
    
    
    September 2022
67. LI L, Tu B, Liu S, Zhang Z, et al
    Sex differences in ventricular arrhythmias epidemiology, risk factors, and mortality in congestive heart failure.
    Int J Cardiol. 2022 Sep 28. pii: S0167-5273(22)01415.
    PubMed     Abstract available
    
    
    
68. PICCINNI C, Dondi L, Calabria S, Ronconi G, et al
    How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01403.
    PubMed     Abstract available
    
    
    
69. LI X, Zuo C, Chen C, Tian D, et al
    Effectiveness and safety evaluation of sacubitril/valsartan in blood pressure control and clinical outcomes for elderly patients with heart failure and hypertension: A prospective cohort study.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01400.
    PubMed     Abstract available
    
    
    
70. AMIOKA M, Sanada R, Matsumura H, Kinoshita H, et al
    Impact of SGLT2 inhibitors on old age patients with heart failure and chronic kidney disease.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01409.
    PubMed     Abstract available
    
    
    
71. JARJOUR M, Leclerc J, Bouabdallaoui N, Ahnadi C, et al
    Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomes.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01408.
    PubMed     Abstract available
    
    
    
72. ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
    Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
    Int J Cardiol. 2022;363:1-5.
    PubMed     Abstract available
    
    
    
73. STAMATELOPOULOS K, Delialis D, Georgiopoulos G, Tselegkidi MI, et al
    Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.
    Int J Cardiol. 2022;363:102-110.
    PubMed     Abstract available
    
    
    
74. YANG CD, Aihemaiti M, Quan JW, Chen JW, et al
    HbA1c level is associated with the development of heart failure with recovered ejection fraction in hospitalized heart failure patients with type 2 diabetes.
    Int J Cardiol. 2022 Sep 15. pii: S0167-5273(22)01339.
    PubMed     Abstract available
    
    
    
75. SEFEROVIC PM, Polovina M, Seferovic J, Rosano G, et al
    Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes.
    Int J Cardiol. 2022 Sep 14. pii: S0167-5273(22)01328.
    PubMed    
    
    
    
76. HIGUCHI S, Orban M, Adamo M, Giannini C, et al
    Sex-specific impact of anthropometric parameters on outcomes after transcatheter edge-to-edge repair for secondary mitral regurgitation.
    Int J Cardiol. 2022 Sep 14. pii: S0167-5273(22)01337.
    PubMed     Abstract available
    
    
    
77. MAHABADI AA, Anapliotis V, Dykun I, Rassaf T, et al
    Response to: Epicardial adipose tissue in heart failure: A promising therapeutic target.
    Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01326.
    PubMed    
    
    
    
78. MIAO C, Tang ZW, Nie F
    Epicardial adipose tissue in heart failure: A promising therapeutic target.
    Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01327.
    PubMed    
    
    
    
79. PASTORE MC, Mandoli GE, Stefanini A, Ghionzoli N, et al
    Prediction of congestive state in acute and chronic heart failure: The association between NT-proBNP and left atrial strain and its prognostic value.
    Int J Cardiol. 2022 Sep 3. pii: S0167-5273(22)01266.
    PubMed     Abstract available
    
    
    
80. BURRI H
    Electrical remodeling and super-response with biventricular and conduction system pacing: Can cardiac resynchronization therapy be curative?
    Int J Cardiol. 2022;362:83-84.
    PubMed    
    
    
    
81. KHAZAEI S, Khazaei M
    Comment on: Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy.
    Int J Cardiol. 2022;362:152.
    PubMed    
    
    
    August 2022
82. GIL FR, Brida M
    Response to Letter Regarding Article 'Heart failure in adults with congenital heart disease'.
    Int J Cardiol. 2022 Aug 24. pii: S0167-5273(22)01255.
    PubMed    
    
    
    
83. OGAWA M, Yoshida N, Nakai M, Kanaoka K, et al
    Hospital-associated disability and hospitalization costs for acute heart failure stratified by body mass index- insight from the JROAD/JROAD-DPC database.
    Int J Cardiol. 2022 Aug 24. pii: S0167-5273(22)01254.
    PubMed     Abstract available
    
    
    
84. GHAJAR A, Ordonez CP, Philips B, Pinzon PQ, et al
    Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes.
    Int J Cardiol. 2022 Aug 21. pii: S0167-5273(22)01253.
    PubMed     Abstract available
    
    
    
85. LI S, Zheng Y, Huang Y, He W, et al
    Association of body mass index and prognosis in patients with HFpEF: A dose-response meta-analysis.
    Int J Cardiol. 2022;361:40-46.
    PubMed     Abstract available
    
    
    
86. PAPANASTASIOU CA, Bazmpani MA, Kokkinidis DG, Zegkos T, et al
    The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Aug 9. pii: S0167-5273(22)01175.
    PubMed     Abstract available
    
    
    
87. TSCHOPE C, Nelki V, Trippel TD, Klingel K, et al
    Safety and usefulness of left ventricular endomyocardial biopsy in new- onset acute heart failure requiring mechanical support by an Impella(R) device.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01176.
    PubMed     Abstract available
    
    
    
88. GARATTI L, Frea S, Bocchino PP, Angelini F, et al
    Sodium nitroprusside in acute heart failure: A multicenter historic cohort study.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01177.
    PubMed     Abstract available
    
    
    
89. LIM HS
    How does protocolization improve outcomes in cardiogenic shock due to end-stage heart failure?
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01115.
    PubMed     Abstract available
    
    
    
90. AIMO A, Lupon J, Spitaleri G, Domingo M, et al
    Global warming, renal function and heart failure over 20years.
    Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01113.
    PubMed     Abstract available
    
    
    July 2022
91. TANG SS, Wang XJ, Tang CK
    The authors' reply to the letter "CA125 a cause or an effect in heart failure?"
    Int J Cardiol. 2022 Jul 31. pii: S0167-5273(22)01114.
    PubMed    
    
    
    
92. CHISHIKI T, Nagatomo Y, Saji M, Takei M, et al
    Divergent effect of blood glucose dysregulation on long-term clinical outcome in acute decompensated heart failure: A reappraisal in contemporary practice.
    Int J Cardiol. 2022 Jul 25. pii: S0167-5273(22)01111.
    PubMed     Abstract available
    
    
    
93. PINTALHAO M, Vasques-Novoa F, Couto-Viana B, Pimentel MJ, et al
    Relaxin-2, pathophysiological insights and outcomes in heart failure with preserved ejection fraction: Findings from the NETDiamond cohort.
    Int J Cardiol. 2022 Jul 20. pii: S0167-5273(22)01106.
    PubMed     Abstract available
    
    
    
94. AREVALO-LORIDO JC, Carretero-Gomez J
    The circular pathway for the improvement of readmitting heart failure patients.
    Int J Cardiol. 2022 Jul 20. pii: S0167-5273(22)01099.
    PubMed    
    
    
    
95. AUSTIN DE, Lee DS, Wang CX, Ma S, et al
    Comparison of machine learning and the regression-based EHMRG model for predicting early mortality in acute heart failure.
    Int J Cardiol. 2022 Jul 19. pii: S0167-5273(22)01105.
    PubMed     Abstract available
    
    
    
96. GODINO C, Scotti A, Marengo A, Battini I, et al
    Effectiveness and cost-efficacy of diuretics home administration via peripherally inserted central venous catheter in patients with end-stage heart failure.
    Int J Cardiol. 2022 Jul 16. pii: S0167-5273(22)01095.
    PubMed     Abstract available
    
    
    
97. MOOLLA M, Mathew A, John K, Yogasundaram H, et al
    Outcomes of pregnancy in women with hypertrophic cardiomyopathy: A systematic review.
    Int J Cardiol. 2022;359:54-60.
    PubMed     Abstract available
    
    
    
98. CHENG B, Zhong JP, Fu WJ, Chen HJ, et al
    Microfiber-associated protein 5 (MFAP5): A promising approach to discover new biomarkers for heart failure and cardiac remodeling.
    Int J Cardiol. 2022 Jul 7. pii: S0167-5273(22)01033.
    PubMed    
    
    
    
99. SHAMAKI GR, Kesiena O, Markson F, Andrew M, et al
    Editorial of "Heart failure with normal LVEF in BIOSTAT-CHF" to International Journal of Cardiology".
    Int J Cardiol. 2022 Jul 1. pii: S0167-5273(22)01021.
    PubMed    
    
    
    
100. SWARTZ AM, Wamsley C, Crownover E, Tarima S, et al
     Move more and sit less pilot intervention for individuals with heart failure.
     Int J Cardiol. 2022 Jul 1. pii: S0167-5273(22)01023.
     PubMed     Abstract available
     
     
     June 2022
101. YANO M, Nishino M, Ukita K, Kawamura A, et al
     Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction.
     Int J Cardiol. 2022 Jun 29. pii: S0167-5273(22)01014.
     PubMed     Abstract available
     
     
     
102. YOUNES AM, Salem M, Maraey A, Nomigolzar S, et al
     Safety outcomes of SGLT2i in the heart failure trials: A systematic review and Meta-analysis.
     Int J Cardiol. 2022 Jun 28. pii: S0167-5273(22)01012.
     PubMed     Abstract available
     
     
     
103. BAUDO M, D'Ancona G, Trinca F, Rosati F, et al
     Atrioventricular node ablation and pacing for atrial tachyarrhythmias: A meta-analysis of postoperative outcomes.
     Int J Cardiol. 2022 Jun 25. pii: S0167-5273(22)01011.
     PubMed     Abstract available
     
     
     
104. RABKIN SW
     Heart failure with reduced ejection fraction and diastolic dysfunction (HrEFwDD): Time for a new clinical entity.
     Int J Cardiol. 2022 Jun 24. pii: S0167-5273(22)01008.
     PubMed    
     
     
     
105. KIM SE, Cho DH, Son JW, Kim JY, et al
     Impact of NT-proBNP on prognosis of acute decompensated chronic heart failure versus de novo heart failure.
     Int J Cardiol. 2022 Jun 23. pii: S0167-5273(22)01007.
     PubMed     Abstract available
     
     
     
106. COWIE MR, Mourilhe-Rocha R, Chang HY, Volterrani M, et al
     The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE heart failure care network.
     Int J Cardiol. 2022 Jun 21. pii: S0167-5273(22)00922.
     PubMed     Abstract available
     
     
     
107. EPSTEIN E, Schale S, Brambatti M, You H, et al
     Impact of Transitioning Patients to Oral Diuretics 24 Hours Before Discharge from Heart Failure Hospitalization on 30 Day Outcomes.
     Int J Cardiol. 2022 Jun 20. pii: S0167-5273(22)00930.
     PubMed     Abstract available
     
     
     
108. CANEPA M, Leporatti L, Persico L, Ameri P, et al
     Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy.
     Int J Cardiol. 2022 Jun 18. pii: S0167-5273(22)00951.
     PubMed     Abstract available
     
     
     
109. IMRAN TF, Mohebali D, Lopez D, Goli RR, et al
     NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy.
     Int J Cardiol. 2022;357:48-54.
     PubMed     Abstract available
     
     
     
110. QIAN Z, Qin C, Zou F, Xue S, et al
     Complete electrical reverse remodeling of native conduction after resynchronization therapies.
     Int J Cardiol. 2022;357:81-87.
     PubMed     Abstract available
     
     
     
111. SEIDEL F, Opgen-Rhein B, Rentzsch A, Boehne M, et al
     Clinical characteristics and outcome of biopsy-proven myocarditis in children - Results of the German prospective multicentre registry "MYKKE".
     Int J Cardiol. 2022;357:95-104.
     PubMed     Abstract available
     
     
     
112. JOURY A, Ventura H, Krim SR
     Biomarkers in heart failure: Relevance in the clinical practice.
     Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00935.
     PubMed     Abstract available
     
     
     
113. KIM CH, Hwang IC, Choi HM, Ahn CH, et al
     Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus.
     Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00927.
     PubMed     Abstract available
     
     
     
114. DE LANGE I, Petersen TB, de Bakker M, Akkerhuis KM, et al
     Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study).
     Int J Cardiol. 2022 Jun 14. pii: S0167-5273(22)00919.
     PubMed     Abstract available
     
     
     
115. SHANG L, Sun H, Tang B, Hou Y, et al
     Metabolic disorders as growing risk factors and comorbidities in heart failure.
     Int J Cardiol. 2022 Jun 2. pii: S0167-5273(22)00822.
     PubMed    
     
     
     
116. IKEDA S, Shinohara K, Enzan N, Matsushima S, et al
     Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type 2 diabetes mellitus without known cardiovascular disease.
     Int J Cardiol. 2022;356:98-104.
     PubMed     Abstract available
     
     
     
117. SABATINO J, Di Salvo G
     The new pandemic: ACHD HF.
     Int J Cardiol. 2022;356:51-52.
     PubMed    
     
     
     May 2022
118. LEE SY, Jung MH
     Sex-related differences among young adults with heart failure: Does sex matter?
     Int J Cardiol. 2022 May 31. pii: S0167-5273(22)00808.
     PubMed    
     
     
     
119. HE S, Zhu H, Zhang J, Wu X, et al
     Proteomic analysis of epicardial adipose tissue from heart disease patients with concomitant heart failure with preserved ejection fraction.
     Int J Cardiol. 2022 May 31. pii: S0167-5273(22)00814.
     PubMed     Abstract available
     
     
     
120. BAUMHOVE L, Tromp J, Figarska S, van Essen BJ, et al
     Heart failure with normal LVEF in BIOSTAT-CHF.
     Int J Cardiol. 2022 May 29. pii: S0167-5273(22)00765.
     PubMed     Abstract available
     
     
     
121. RIBEIRO GDS, Deresz LF, Salvioni E, Hansen D, et al
     Sensitivity and specificity of different exercise oscillatory ventilation definitions to predict 2-year major adverse cardiovascular outcomes in chronic heart failure patients.
     Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00753.
     PubMed     Abstract available
     
     
     
122. LIMD Z, LiMD S
     CA125 a cause or an effect in heart failure?
     Int J Cardiol. 2022 May 23. pii: S0167-5273(22)00760.
     PubMed    
     
     
     
123. MOHAMMED SA
     Editorial: Left, but not right, ventricular status determines heart failure in adults with Ebstein anomaly- a case-control study based on magnetic resonance.
     Int J Cardiol. 2022 May 19. pii: S0167-5273(22)00749.
     PubMed    
     
     
     
124. STASSEN J, Khidir M, Galloo X, Hirasawa K, et al
     Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy.
     Int J Cardiol. 2022;355:65-71.
     PubMed     Abstract available
     
     
     
125. IWATSU K, Ikeda T, Matsumura K, Ashikawa H, et al
     Gap in the prognostic impact of short physical performance battery among phenotypes of heart failure.
     Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00656.
     PubMed     Abstract available
     
     
     
126. ANGUITA E, Chaparro A, Candel FJ, Ramos-Acosta C, et al
     Biomarkers of stable and decompensated phases of heart failure with preserved ejection fraction.
     Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00655.
     PubMed     Abstract available
     
     
     April 2022
127. FRIGELLI M, Sturla F, Milani V, Ramputi L, et al
     Prognostic value of left atrial strain quantification from 2D ultrasound imaging in post-ischemic heart failure patients: evidence from the REMODEL-HF study.
     Int J Cardiol. 2022 Apr 30. pii: S0167-5273(22)00633.
     PubMed     Abstract available
     
     
     
128. BASIC C, Rosengren A, Dahlstrom U, Edner M, et al
     Sex-related differences among young adults with heart failure in Sweden.
     Int J Cardiol. 2022 Apr 28. pii: S0167-5273(22)00635.
     PubMed     Abstract available
     
     
     
129. CIARDULLO S, Cannistraci R, Mazzetti S, Mortara A, et al
     Twenty-year trends in heart failure among U.S. adults, 1999-2018: The growing impact of obesity and diabetes.
     Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00578.
     PubMed     Abstract available
     
     
     
130. YU X
     Heart failure with improved ejection fraction: The current and future in Asian populations.
     Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00579.
     PubMed    
     
     
     
131. CIEPLUCHA A, Trojnarska O, Rajewska-Tabor J, Bartczak-Rutkowska A, et al
     Left, but not right, ventricular status determines heart failure in adults with Ebstein anomaly - A case-control study based on magnetic resonance.
     Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00585.
     PubMed     Abstract available
     
     
     
132. LI L, Zhang Z, Xiong Y, Hu Z, et al
     Prediction of hospital mortality in mechanically ventilated patients with congestive heart failure using machine learning approaches.
     Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00581.
     PubMed     Abstract available
     
     
     
133. BERGONTI M, Spera F, Tijskens M, Bonomi A, et al
     A new prediction model for left ventricular systolic function recovery after catheter ablation of atrial fibrillation in patients with heart failure.
     Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00554.
     PubMed     Abstract available
     
     
     
134. CASTIGLIONE V, Vergaro G, Emdin M
     Targeting precipitants to prevent heart failure hospitalization. Does season matter?
     Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00561.
     PubMed    
     
     
     
135. RIZZO M, Cianflone D, Maranta F
     Treatment of diabetes and heart failure: Facts and hopes.
     Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00549.
     PubMed    
     
     
     
136. YALCIN YC, Veenis JF, Brugts JJ, Antonides CFJ, et al
     Rate of thromboembolic and bleeding events in patients undergoing concomitant aortic valve surgery with left ventricular assist device implantation.
     Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00555.
     PubMed     Abstract available
     
     
     
137. ELBADAWI A, Tan BE, Assaf Y, Megaly M, et al
     Digital health intervention in patients with recent hospitalization for acute heart failure: A systematic review and meta-analysis of randomized trials.
     Int J Cardiol. 2022 Apr 15. pii: S0167-5273(22)00553.
     PubMed     Abstract available
     
     
     
138. SHOJI S, Kohsaka S, Shiraishi Y, Kohno T, et al
     Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trials.
     Int J Cardiol. 2022 Apr 11. pii: S0167-5273(22)00500.
     PubMed     Abstract available
     
     
     
139. MAHABADI AA, Anapliotis V, Dykun I, Hendricks S, et al
     Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.
     Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00489.
     PubMed     Abstract available
     
     
     
140. ROSENTHAL LL, Ulrich SM, Zimmerling L, Brenner P, et al
     Pediatric heart transplantation in infants and small children under 3years of age: Single center experience - "Early and long-term results".
     Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00482.
     PubMed     Abstract available
     
     
     
141. FERREIRA JP, Shah AM, Claggett BL, Pitt B, et al
     Cardiac structure and function and quality of life associations in HFpEF: An analysis from TOPCAT-Americas.
     Int J Cardiol. 2022;352:78-83.
     PubMed     Abstract available
     
     
     March 2022
142. SENGUPTA SP, Okwose NC, MacGowan GA, Jakovljevic DG, et al
     Peak atrio-ventricular mechanics predicts exercise tolerance in heart failure patients.
     Int J Cardiol. 2022 Mar 31. pii: S0167-5273(22)00442.
     PubMed     Abstract available
     
     
     
143. SU K, Li M, Wang L, Tian S, et al
     Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction.
     Int J Cardiol. 2022 Mar 23. pii: S0167-5273(22)00405.
     PubMed     Abstract available
     
     
     
144. SATO T, Kobayashi Y, Nagai T, Nakatani T, et al
     Long-term preservation of functional capacity and quality of life in advanced heart failure patients with bridge to transplant therapy: A report from Japanese nationwide multicenter registry.
     Int J Cardiol. 2022 Mar 22. pii: S0167-5273(22)00403.
     PubMed     Abstract available
     
     
     
145. ZHANG Y
     Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
     Int J Cardiol. 2022 Mar 18. pii: S0167-5273(22)00389.
     PubMed    
     
     
     
146. ESPERSEN C, Modin D, Platz E, Jensen GB, et al
     Global and regional wall motion abnormalities and incident heart failure in the general population.
     Int J Cardiol. 2022 Mar 15. pii: S0167-5273(22)00386.
     PubMed     Abstract available
     
     
     
147. AIMO A, Lupon J, Bayes-Genis A, Emdin M, et al
     Urinary NGAL in acute heart failure revisited: the game is not over yet.
     Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00382.
     PubMed    
     
     
     
148. MINISTRINI S
     Could serum carboxyterminal telopeptide of collagen type I (CITP) have a role in the early diagnosis of heart failure with preserved ejection fraction (HFpEF)?
     Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00383.
     PubMed    
     
     
     
149. JAYAGOPAL PB, Sastry SL, Nanjappa V, Abdullakutty J, et al
     Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR).
     Int J Cardiol. 2022 Mar 13. pii: S0167-5273(22)00381.
     PubMed     Abstract available
     
     
     
150. BRIDA M, Lovric D, Griselli M, Gil FR, et al
     Heart failure in adults with congenital heart disease.
     Int J Cardiol. 2022 Mar 10. pii: S0167-5273(22)00337.
     PubMed     Abstract available
     
     
     
151. BILLINGSLEY HE, Canada JM, Dixon DL, Kirkman DL, et al
     Midpoint of energy intake, non-fasting time and cardiorespiratory fitness in heart failure with preserved ejection fraction and obesity.
     Int J Cardiol. 2022 Mar 8. pii: S0167-5273(22)00330.
     PubMed     Abstract available
     
     
     February 2022
152. HORIUCHI Y, Wettersten N, van Veldhuisen DJ, Mueller C, et al
     Decongestion, kidney injury and prognosis in patients with acute heart failure.
     Int J Cardiol. 2022 Feb 21. pii: S0167-5273(22)00261.
     PubMed     Abstract available
     
     
     
153. CHIANG B, Chew DP, De Pasquale CG
     Outcome trial data on sodium glucose cotransporter-2 inhibitors: Putting clinical benefits and risks in perspective.
     Int J Cardiol. 2022;349:96-98.
     PubMed     Abstract available
     
     
     
154. TINI G, Cuomo A, Battistoni A, Sarocchi M, et al
     Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice.
     Int J Cardiol. 2022;349:134-137.
     PubMed     Abstract available
     
     
     
155. ROJAS LZ, Gomez-Ochoa SA, Echeverria LE, Bautista-Nino PK, et al
     Circulating DHEA-S levels and major cardiovascular outcomes in chronic Chagas cardiomyopathy: A prospective cohort study.
     Int J Cardiol. 2022;349:90-95.
     PubMed     Abstract available
     
     
     
156. MANTOVANI A, Bonapace S, Dugo C, Beatrice G, et al
     Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
     Int J Cardiol. 2022 Feb 12. pii: S0167-5273(22)00248.
     PubMed     Abstract available
     
     
     
157. DURAN A, De Anda-Duran I, Ventura HO
     The era of heart failure risk prediction models, is it time to test their utility?
     Int J Cardiol. 2022 Feb 9. pii: S0167-5273(22)00218.
     PubMed    
     
     
     
158. CHARANSONNEY OL
     SGLT-2 inhibitors in frail patients with heart failure.
     Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00193.
     PubMed    
     
     
     
159. GIRERD N
     The growing importance of heart failure in myocardial infarction.
     Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00194.
     PubMed    
     
     
     
160. SALA A, Lorusso R, Alfieri O
     Isolated tricuspid regurgitation: A plea for early correction.
     Int J Cardiol. 2022 Feb 4. pii: S0167-5273(22)00195.
     PubMed     Abstract available
     
     
     
161. TRAMBAIOLO P, Figliuzzi I, Salvati M, Bertini P, et al
     Ventriculo-arterial coupling in the intensive cardiac care unit: A non-invasive prognostic parameter.
     Int J Cardiol. 2022;348:85-89.
     PubMed     Abstract available
     
     
     
162. AHMED S, Ahmed A, Radegran G
     The Authors' Reply to the Letter "Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis".
     Int J Cardiol. 2022;348:108.
     PubMed    
     
     
     January 2022
163. ROVAI S, Contini M, Sciomer S, Vignati C, et al
     The double anaerobic threshold in heart failure.
     Int J Cardiol. 2022 Jan 25. pii: S0167-5273(22)00136.
     PubMed     Abstract available
     
     
     
164. DONAL E, L'official G, Kosmala W
     New guidelines for managing chronic heart failure patients and new needs in echocardiography.
     Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00125.
     PubMed    
     
     
     
165. SCRUTINIO D, Guida P, Passantino A, Scalvini S, et al
     Association of improvement in functional capacity after rehabilitation with long-term survival in heart failure.
     Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00129.
     PubMed     Abstract available
     
     
     
166. CHANG GM, Chen JY, Kuo WY, Tung YC, et al
     Associations of continuity and coordination of care with outcomes and costs after discharge among patients with heart failure: A nationwide population-based study.
     Int J Cardiol. 2022 Jan 19. pii: S0167-5273(22)00118.
     PubMed     Abstract available
     
     
     
167. ZHENG H, Liang J, Chen X, Chen X, et al
     Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis.
     Int J Cardiol. 2022;347:64-65.
     PubMed    
     
     
     
168. CARLUCCIO E, Dini FL, Bitto R, Ciccarelli M, et al
     Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study.
     Int J Cardiol. 2022 Jan 5. pii: S0167-5273(22)00004.
     PubMed     Abstract available
     
     
     
169. GIANNONI A, Sciarrone P
     Prognostic impact of diabetes in heart failure: looking back to move forward.
     Int J Cardiol. 2022 Jan 4. pii: S0167-5273(22)00005.
     PubMed    
     
     
     December 2021
170. DRISCOLL A, Romanuick H, Dinh D, Amerena J, et al
     Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure.
     Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02053.
     PubMed     Abstract available
     
     
     
171. GIACCARI A, Pontremoli R, Filardi PP
     SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice.
     Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02054.
     PubMed     Abstract available
     
     
     
172. RIND IA, Cannata A, McDonaugh B, Cassimon B, et al
     Patients hospitalised with heart failure across different waves of the COVID-19 pandemic show consistent clinical characteristics and outcomes.
     Int J Cardiol. 2021 Dec 29. pii: S0167-5273(21)02045.
     PubMed     Abstract available
     
     
     
173. DE LUCA L, Cicala SD, D'Errigo P, Cerza F, et al
     Impact of age, gender and heart failure on mortality trends after acute myocardial infarction in Italy.
     Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02015.
     PubMed     Abstract available
     
     
     
174. BHATIA HS, Nishimura M, Martinez A, Vanam S, et al
     Systolic dysfunction in patients with methamphetamine use and heart failure with preserved ejection fraction.
     Int J Cardiol. 2021 Dec 15. pii: S0167-5273(21)02016.
     PubMed     Abstract available
     
     
     
175. ANABA U, Ishola A, Alabre A, Bui A, et al
     Diversity in modern heart failure trials: Where are we, and where are we going.
     Int J Cardiol. 2021 Dec 14. pii: S0167-5273(21)02010.
     PubMed     Abstract available
     
     
     
176. BALBI C
     Editorial: Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
     Int J Cardiol. 2021 Dec 13. pii: S0167-5273(21)01995.
     PubMed    
     
     
     
177. GUAZZI M, Bursi F, Rusconi F
     Lung Biomarkers: a new route for distinguishing pulmonary hypertension due to HFpEF from pulmonary arterial hypertension.
     Int J Cardiol. 2021 Dec 13. pii: S0167-5273(21)01982.
     PubMed    
     
     
     
178. YANDRAPALLI S, Malik AH, Namrata F, Pemmasani G, et al
     Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations.
     Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01976.
     PubMed     Abstract available
     
     
     
179. SARDU C, Amarelli C
     Continuous flow left ventricular assist devices and cardiac resynchronization: Friends or foe?
     Int J Cardiol. 2021;344:138-139.
     PubMed    
     
     
     
180. LIANG Y, Ding R, Wang J, Gong X, et al
     Prediction of response after cardiac resynchronization therapy with machine learning.
     Int J Cardiol. 2021;344:120-126.
     PubMed     Abstract available
     
     
     November 2021
181. KRIM SR
     Use of plasma renin and aldosterone profiles for prognostication in acute heart failure: A step forward but not ready for prime time.
     Int J Cardiol. 2021 Nov 30. pii: S0167-5273(21)01952.
     PubMed    
     
     
     
182. OSUNDOLIRE S, Naqvi S, Nunes AP, Lapane KL, et al
     Heart failure among US nursing home residents with diabetes mellitus.
     Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01777.
     PubMed     Abstract available
     
     
     
183. KITAI T
     Early intravenous vasodilator therapy in acute decompensated heart failure: Is the time-to-treat concept still applicable in a pre-hospital setting?
     Int J Cardiol. 2021 Nov 20. pii: S0167-5273(21)01859.
     PubMed    
     
     
     
184. REA F, Iorio A, Barbati G, Bessi R, et al
     Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure.
     Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01788.
     PubMed    
     
     
     
185. FUDIM M, Devaraj S, Chukwurah M, Ajam T, et al
     Prognosis for patients with heart failure and reduced ejection fraction with and without diabetes: A 7 year nationwide veteran administration analysis.
     Int J Cardiol. 2021 Nov 17. pii: S0167-5273(21)01849.
     PubMed     Abstract available
     
     
     
186. LAMMERS AE, Sprenger KS, Diller GP, Miera O, et al
     Ventricular assist devices in paediatric cardiomyopathy and congenital heart disease: An analysis of the German National Register for Congenital Heart Defects.
     Int J Cardiol. 2021;343:37-44.
     PubMed     Abstract available
     
     
     
187. GORI M, Marini M, De Maria R, Gonzini L, et al
     Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure.
     Int J Cardiol. 2021 Nov 15. pii: S0167-5273(21)01783.
     PubMed     Abstract available
     
     
     
188. MO M, Xia N, Liao Y
     Letter on "Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials".
     Int J Cardiol. 2021 Nov 13. pii: S0167-5273(21)01839.
     PubMed    
     
     
     
189. TEMPORELLI PL, Arbelo E, Laroche C, Blomstrom-Lundqvist C, et al
     Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry.
     Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01779.
     PubMed     Abstract available
     
     
     
190. PFEIFER P, Zietzer A, Holscher M, Jehle J, et al
     Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
     Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01772.
     PubMed     Abstract available
     
     
     
191. UDANI K, Chris-Olaiya A, Ohadugha C, Malik A, et al
     Cardiovascular manifestations in hospitalized patients with hemochromatosis in the United States.
     Int J Cardiol. 2021;342:117-124.
     PubMed     Abstract available
     
     
     
192. FASTNER C, Yuecel G, Rudic B, Schmiel G, et al
     Cardiac Contractility Modulation in Patients with Ischemic versus Non-ischemic Cardiomyopathy: Results from the MAINTAINED Observational Study.
     Int J Cardiol. 2021;342:49-55.
     PubMed     Abstract available
     
     
     October 2021
193. BIEGUS J, Nawrocka-Millward S, Zymlinski R, Fudim M, et al
     Distinct renin/aldosterone activity profiles correlate with renal function, natriuretic response, decongestive ability and prognosis in acute heart failure.
     Int J Cardiol. 2021 Oct 30. pii: S0167-5273(21)01703.
     PubMed     Abstract available
     
     
     
194. AHMED S, Ahmed A, Radegran G
     Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension.
     Int J Cardiol. 2021 Oct 25. pii: S0167-5273(21)01690.
     PubMed     Abstract available
     
     
     
195. HE Z, Yang L, Nie Y, Wang Y, et al
     Effects of SGLT-2 inhibitors on health-related quality of life and exercise capacity in heart failure patients with reduced ejection fraction: A systematic review and meta-analysis.
     Int J Cardiol. 2021 Oct 12. pii: S0167-5273(21)01562.
     PubMed     Abstract available
     
     
     
196. YOUN JC, Baek SH
     Heart failure risk in younger adults needing more attention.
     Int J Cardiol. 2021 Oct 8. pii: S0167-5273(21)01560.
     PubMed    
     
     
     
197. ARENJA N, Mueller C, Tomilovskaya E, Koryak Y, et al
     Real-world experience of feasibility and efficacy of electrical muscle stimulation in elderly patients with acute heart failure: A randomized controlled study.
     Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01504.
     PubMed     Abstract available
     
     
     
198. DARDEN D, Ammirati E, Brambatti M, Lin A, et al
     Cardiovascular implantable electronic device therapy in patients with left ventricular assist devices: insights from TRAViATA.
     Int J Cardiol. 2021;340:26-33.
     PubMed     Abstract available
     
     
     September 2021
199. MIRO O, Llorens P, Freund Y, Davison B, et al
     Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry.
     Int J Cardiol. 2021 Sep 17. pii: S0167-5273(21)01470.
     PubMed     Abstract available
     
     
     
200. DLOUHA D, Ivak P, Netuka I, Novakova S, et al
     The effect of long-term left ventricular assist device support on flow-sensitive plasma microRNA levels.
     Int J Cardiol. 2021;339:138-143.
     PubMed     Abstract available
     
     
     
201. WEBER C, Hung J, Hickling S, Li I, et al
     Changing age-specific trends in incidence, comorbidities and mortality of hospitalised heart failure in Western Australia between 2001 and 2016.
     Int J Cardiol. 2021 Sep 11. pii: S0167-5273(21)01376.
     PubMed     Abstract available
     
     
     
202. KAPELIOS CJ, Canepa M, Benson L, Hage C, et al
     Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: Observations from The Swedish Heart Failure Registry.
     Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01334.
     PubMed     Abstract available
     
     
     
203. GUIMARAES GV, Ribeiro F, Castro RE, Roque JM, et al
     Effects of the exercise training on skeletal muscle oxygen consumption in heart failure patients with reduced ejection fraction.
     Int J Cardiol. 2021 Sep 7. pii: S0167-5273(21)01318.
     PubMed     Abstract available
     
     
     
204. AMARELLI C, Limongelli G
     Cardiac amyloidosis: Watching the tip of the iceberg emerging from the "heart of the sea".
     Int J Cardiol. 2021;338:226-228.
     PubMed    
     
     
     
205. BODE N, Hochadel M, Andresen D, Zahn R, et al
     Cardiac glycosides are not associated with increased mortality or hospitalization rates in ICD and CRT-ICD patients after adjustment for baseline-characteristics at one-year follow-up: Results from the German DEVICE registry.
     Int J Cardiol. 2021;338:109-114.
     PubMed     Abstract available
     
     
     August 2021
206. MONZO L, Ferrari I, Cicogna F, Tota C, et al
     Sodium-glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction.
     Int J Cardiol. 2021 Aug 26. pii: S0167-5273(21)01301.
     PubMed     Abstract available
     
     
     
207. KANEKO H, Itoh H, Kamiya K, Morita K, et al
     Acute-phase initiation of cardiac rehabilitation and clinical outcomes in hospitalized patients for acute heart failure.
     Int J Cardiol. 2021 Aug 26. pii: S0167-5273(21)01307.
     PubMed     Abstract available
     
     
     
208. NAKAO K, Yasuda S, Noguchi T, Sumita Y, et al
     Association of hospital performance measures with readmissions for patients with heart failure: A report from JROAD-DPC study.
     Int J Cardiol. 2021 Aug 19. pii: S0167-5273(21)01229.
     PubMed     Abstract available
     
     
     
209. VINTER N, Frost L, Benjamin EJ
     Heart failure and atrial fibrillation - does heart failure subtype matter?
     Int J Cardiol. 2021 Aug 6. pii: S0167-5273(21)01216.
     PubMed    
     
     
     
210. TADA A, Nagai T, Omote K, Iwano H, et al
     Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry.
     Int J Cardiol. 2021 Aug 5. pii: S0167-5273(21)01211.
     PubMed     Abstract available
     
     
     July 2021
211. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
     Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
     Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
     PubMed     Abstract available
     
     
     
212. ABBOUD A, Gaggin HK
     Heart failure and frailty: Expanding the gender paradox.
     Int J Cardiol. 2021 Jul 24. pii: S0167-5273(21)01190.
     PubMed    
     
     
     
213. ZHOU Y, Chen S, Rao Z, Yang D, et al
     Prediction of 1-year mortality after heart transplantation using machine learning approaches: A single-center study from China.
     Int J Cardiol. 2021 Jul 13. pii: S0167-5273(21)01169.
     PubMed     Abstract available
     
     
     
214. NJI MAM, Solomon SD, Chen LY, Shah AM, et al
     Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study.
     Int J Cardiol. 2021 Jul 8. pii: S0167-5273(21)01100.
     PubMed     Abstract available
     
     
     
215. VALERIANOVA A, Malik J, Janeckova J, Kovarova L, et al
     Reduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients.
     Int J Cardiol. 2021;334:148-153.
     PubMed     Abstract available
     
     
     June 2021
216. DE LA ESPRIELLA R, Minana G, Santas E, Nunez G, et al
     Effects of empagliflozin on CA125 trajectory in patients with chronic congestive heart failure.
     Int J Cardiol. 2021 Jun 30. pii: S0167-5273(21)01084.
     PubMed     Abstract available
     
     
     
217. ISHIWATA S, Matsue Y, Nakamura Y, Dotare T, et al
     Clinical and prognostic values of urinary alpha1-microglobulin as a tubular marker in acute heart failure.
     Int J Cardiol. 2021 Jun 26. pii: S0167-5273(21)01079.
     PubMed     Abstract available
     
     
     
218. DURAN A, daSilva-deAbreu A, Joury A, Ventura HO, et al
     FGF23 predicts outcomes in heart failure but questions remain unanswered.
     Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01034.
     PubMed    
     
     
     
219. ILONZE OJ, Guglin M
     Vericiguat, organic nitrates, and heart failure in African Americans.
     Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01031.
     PubMed     Abstract available
     
     
     
220. DOLDI PM, Buech J, Orban M, Samson-Himmelstjerna P, et al
     Transcatheter mitral valve repair may increase eligibility for heart transplant listing in patients with end-stage heart failure and severe secondary mitral regurgitation.
     Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01029.
     PubMed     Abstract available
     
     
     
221. KEULARDS DCJ, Bouwmeester S, de Vos AMJ, Dekker LRC, et al
     High microvascular resistance and reduced left atrial strain in patients with coronary microvascular dysfunction: The micro-strain study.
     Int J Cardiol. 2021;333:21-28.
     PubMed     Abstract available
     
     
     
222. DASILVA-DEABREU A, Lavie CJ, Mehra MR
     Bridging the palliative care chasm in advanced heart failure.
     Int J Cardiol. 2021 Jun 15. pii: S0167-5273(21)00969.
     PubMed    
     
     
     
223. WANG M, Luo B
     Levosimendan is safe to patients with advanced heart failure and hypotension.
     Int J Cardiol. 2021 Jun 9. pii: S0167-5273(21)00914.
     PubMed    
     
     
     
224. EMOTO T, Hayashi T, Tabata T, Yamashita T, et al
     Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
     Int J Cardiol. 2021 Jun 5. pii: S0167-5273(21)00962.
     PubMed     Abstract available
     
     
     
225. LIU L, Lima JAC, Post WS, Szklo M, et al
     Associations of time-varying obesity and metabolic syndrome with risk of incident heart failure and its subtypes: Findings from the Multi-Ethnic Study of Atherosclerosis.
     Int J Cardiol. 2021 Jun 2. pii: S0167-5273(21)00908.
     PubMed     Abstract available
     
     
     
226. POTRATZ M, Fox H, Rudolph V, Faber L, et al
     Respiratory dyssynchrony is a predictor of prognosis in patients with hypertrophic non-obstructive cardiomyopathy.
     Int J Cardiol. 2021;332:105-112.
     PubMed     Abstract available
     
     
     May 2021
227. AIMO A
     Longitudinal changes in cardiac biomarkers and outcome in heart failure: Sex-related differences.
     Int J Cardiol. 2021 May 18. pii: S0167-5273(21)00839.
     PubMed    
     
     
     
228. VERGARO G, Aimo A, Taurino E, Del Franco A, et al
     Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure.
     Int J Cardiol. 2021 May 18. pii: S0167-5273(21)00840.
     PubMed     Abstract available
     
     
     
229. SAMUEL TJ, Wei J, Sharif B, Tamarappoo BK, et al
     Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging.
     Int J Cardiol. 2021;331:1-7.
     PubMed     Abstract available
     
     
     
230. GALLI E, Smiseth OA MD, PhD, Aalen JM, Larsen CK, et al
     Prognostic utility of the assessment of diastolic function in patients undergoing cardiac resynchronization therapy.
     Int J Cardiol. 2021;331:144-151.
     PubMed     Abstract available
     
     
     
231. MACGOWAN GA, Woods A, Robinson-Smith N, Tovey S, et al
     Using existing technology better: Improving outcomes with the HeartWare left ventricular assist device.
     Int J Cardiol. 2021;331:35-39.
     PubMed     Abstract available
     
     
     
232. SHARIATI F, Baldawi H, Bob-Manuel T
     Editorial: Premature death from heart failure among Aboriginal peoples in the Hunter New England region of new South Wales.
     Int J Cardiol. 2021 May 14. pii: S0167-5273(21)00838.
     PubMed    
     
     
     
233. KAMIYA K, Adachi T, Iwatsu K, Kamisaka K, et al
     Association between a pre-admission limitation in walking ability and post-discharge adverse outcomes among hospitalized patients with heart failure: Report from a multicenter prospective cohort study.
     Int J Cardiol. 2021 May 12. pii: S0167-5273(21)00832.
     PubMed     Abstract available
     
     
     
234. SACCO A, Morici N, Villanova L, Viola G, et al
     Withdrawal of active treatments in terminally ill heart failure patients.
     Int J Cardiol. 2021 May 5. pii: S0167-5273(21)00815.
     PubMed     Abstract available
     
     
     
235. KLEIN HU
     Cardiac resynchronization therapy with- or without defibrillator. Estimating the risk of arrhythmic death or assessing the likelihood of non-arrhythmic mortality?
     Int J Cardiol. 2021;330:82-83.
     PubMed    
     
     
     April 2021
236. SCHREUDER MM, Schuurman A, Akkerhuis KM, Constantinescu AA, et al
     Sex-specific temporal evolution of circulating biomarkers in patients with chronic heart failure with reduced ejection fraction.
     Int J Cardiol. 2021 Apr 30. pii: S0167-5273(21)00804.
     PubMed     Abstract available
     
     
     
237. GORI M, Claggett B, Senni M, Shah AM, et al
     Combining diastolic dysfunction and natriuretic peptides to risk stratify patients with heart failure with reduced ejection fraction.
     Int J Cardiol. 2021 Apr 19. pii: S0167-5273(21)00664.
     PubMed     Abstract available
     
     
     
238. AIMO A, Manetti S, Emdin M
     How much is it to mend a broken heart? Results from the US Nationwide Readmission Database.
     Int J Cardiol. 2021;329:150-151.
     PubMed    
     
     
     
239. MCGEE M, Sugito S, Al-Omary MS, Hartnett D, et al
     Heart failure outcomes in Aboriginal and Torres Strait Islander peoples in the Hunter New England region of New South Wales.
     Int J Cardiol. 2021 Apr 8. pii: S0167-5273(21)00637.
     PubMed     Abstract available
     
     
     
240. LI X, Zhang Q, Zhu L, Wang G, et al
     Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials.
     Int J Cardiol. 2021 Apr 7. pii: S0167-5273(21)00636.
     PubMed     Abstract available
     
     
     
241. CAO M, Stolen CM, Ahmed R, Schloss EJ, et al
     Small decreases in biventricular pacing percentages are associated with multiple metrics of worsening heart failure as measured from a cardiac resynchronization therapy defibrillator.
     Int J Cardiol. 2021 Apr 1. pii: S0167-5273(21)00632.
     PubMed     Abstract available
     
     
     
242. QAMRUDDIN S, Ventura HO
     Serial echocardiographic parameters to evaluate prognosis in patients with HFrEF - is it worth the second test?
     Int J Cardiol. 2021;328:141-142.
     PubMed    
     
     
     
243. REINHOLD J, Papadopoulou C, Baral R, Vassiliou VS, et al
     Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis.
     Int J Cardiol. 2021;328:46-54.
     PubMed     Abstract available
     
     
     
244. COHEN ARAZI H, Chirino D, Costabel JP, Pulmari CA, et al
     Leuko-platelet index predicts thrombotic events in patients with acute coronary syndrome.
     Int J Cardiol. 2021;328:29-34.
     PubMed     Abstract available
     
     
     March 2021
245. JACKSON AO, Rahman GA, Long S
     Attenuating senescence and dead cells accumulation as heart failure therapy: Break the communication networks.
     Int J Cardiol. 2021 Mar 29. pii: S0167-5273(21)00565.
     PubMed    
     
     
     
246. SURKOVA E, Dimopoulos K, Li W
     Reply to: "Systolic dysfunction of the subpulmonary left ventricle in the systemic right ventricle: late manifestation or subclinical predictor of heart failure?"
     Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00621.
     PubMed     Abstract available
     
     
     
247. LAINSCAK M, Omersa D, Rosano G, Farkas J, et al
     Pharmacotherapy adherence in patients with heart failure: Easier said than done.
     Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00555.
     PubMed    
     
     
     
248. LI Y, Li L, Wang C
     Insulin-like growth factor binding protein 2 might be a novel therapeutic target in the treatment of heart failure.
     Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00549.
     PubMed    
     
     
     
249. COHEN S, Liu A, Abrahamowicz M, Brophy JM, et al
     Reply to "Risk prediction models for heart failure admissions in adults with congenital heart disease: Methodological issues".
     Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00482.
     PubMed    
     
     
     
250. TANG L, Liu J, Zheng J
     Targeting mitochondrial calcium uniporter in heart failure.
     Int J Cardiol. 2021 Mar 16. pii: S0167-5273(21)00485.
     PubMed    
     
     
     
251. AL-WAKEEL-MARQUARD N, Seidel F, Herbst C, Kuhnisch J, et al
     Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
     Int J Cardiol. 2021 Mar 15. pii: S0167-5273(21)00480.
     PubMed     Abstract available
     
     
     
252. GHIO S, Carluccio E, Scardovi AB, Dini FL, et al
     Prognostic relevance of Doppler echocardiographic re-assessment in HFrEF patients.
     Int J Cardiol. 2021;327:111-116.
     PubMed     Abstract available
     
     
     
253. KOCHAV SM, Raita Y, Fifer MA, Takayama H, et al
     Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
     Int J Cardiol. 2021;327:117-124.
     PubMed     Abstract available
     
     
     
254. CARLUCCIO E, Pugliese NR, Biagioli P, Zuchi C, et al
     Global longitudinal strain in heart failure with reduced ejection fraction: Prognostic relevance across disease severity as assessed by automated cluster analysis.
     Int J Cardiol. 2021 Mar 10. pii: S0167-5273(21)00383.
     PubMed     Abstract available
     
     
     
255. HIGUCHI S, Shibata S, Hasegawa H, Matsuda T, et al
     Reply to the letter to the editor: "Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia".
     Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00458.
     PubMed    
     
     
     
256. STIENEN S, Ferreira JP, Bar C, Thum T, et al
     Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction.
     Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00399.
     PubMed     Abstract available
     
     
     
257. BARISON A, Aimo A, Emdin M
     Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset.
     Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00387.
     PubMed    
     
     
     
258. OLSEN FJ, Biering-Sorensen T
     Right atrial strain: Tapping into a new reservoir of hemodynamic information.
     Int J Cardiol. 2021;326:226-228.
     PubMed    
     
     
     
259. YEUNG DF, Jiang R, Behnami D, Jue J, et al
     Impact of the updated diastolic function guidelines in the real world.
     Int J Cardiol. 2021;326:124-130.
     PubMed     Abstract available
     
     
     
260. SAVIRA F, Kompa AR, Edgley AJ, Jucker BM, et al
     RE: Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis.
     Int J Cardiol. 2021;326:156.
     PubMed    
     
     
     February 2021
261. DAVIS MR, Lee CS, Corcoran A, Gupta N, et al
     Gender differences in the prevalence of frailty in heart failure: A systematic review and meta-analysis.
     Int J Cardiol. 2021 Feb 28. pii: S0167-5273(21)00371.
     PubMed     Abstract available
     
     
     
262. NITTA G, Inaba O, Kato S, Kono T, et al
     Catheter ablation for atrial fibrillation in patients with congestive heart failure.
     Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00369.
     PubMed     Abstract available
     
     
     
263. PAOLILLO S, Salvioni E, Perrone Filardi P, Bonomi A, et al
     Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652].
     Int J Cardiol. 2021 Feb 25. pii: S0167-5273(21)00354.
     PubMed    
     
     
     
264. VAN DEN EYNDE J, Santens B, Van De Bruaene A, Budts W, et al
     Systolic dysfunction of the subpulmonary left ventricle in the systemic right ventricle: Late manifestation or subclinical predictor of heart failure?
     Int J Cardiol. 2021 Feb 25. pii: S0167-5273(21)00368.
     PubMed    
     
     
     
265. RAJDEV K, Lahan S, Wichman T
     Role of pulmonary arterial capacitance in predicting mortality in patients with pulmonary hypertension: A systematic review and meta-analysis.
     Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00296.
     PubMed     Abstract available
     
     
     
266. ELBADAWI A, Dang A, Elgendy IY, Thakker R, et al
     Age-specific trends and outcomes of hospitalizations with acute heart failure in the United States.
     Int J Cardiol. 2021 Feb 17. pii: S0167-5273(21)00284.
     PubMed     Abstract available
     
     
     
267. HSIAO FC, Lin CP, Tung YC, Chang PC, et al
     Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional study.
     Int J Cardiol. 2021 Feb 12. pii: S0167-5273(21)00288.
     PubMed     Abstract available
     
     
     
268. SCALVINI S, Bernocchi P, Villa S, Paganoni AM, et al
     Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100,785 patients.
     Int J Cardiol. 2021 Feb 11. pii: S0167-5273(21)00267.
     PubMed     Abstract available
     
     
     
269. PASSINO C, Sciarrone P, Vergaro G, Borrelli C, et al
     Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction.
     Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00263.
     PubMed     Abstract available
     
     
     
270. WANG X, Li X
     Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia.
     Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00269.
     PubMed    
     
     
     
271. SAKANE K, Kanzaki Y, Hoshiga M
     Reply to "Clinical Significance of B-type Natriuretic Peptide in Patient with Acute Decompensated Heart Failure".
     Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00272.
     PubMed    
     
     
     
272. LEGENDRE A, Moatemri F, Kovalska O, Balice-Pasquinelli M, et al
     Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps.
     Int J Cardiol. 2021 Feb 8. pii: S0167-5273(21)00255.
     PubMed     Abstract available
     
     
     
273. PROUDFOOT C, Studer R, Rajput T, Jindal R, et al
     Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review.
     Int J Cardiol. 2021 Feb 2. pii: S0167-5273(21)00143.
     PubMed     Abstract available
     
     
     
274. VERONESE G, Ammirati E, Chen C, Klingel K, et al
     Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis.
     Int J Cardiol. 2021;324:131-138.
     PubMed     Abstract available
     
     
     January 2021
275. SHETTY S, Malik AH, Ali A, Yang YC, et al
     Characteristics, trends, outcomes, and costs of stimulant-related acute heart failure hospitalizations in the United States.
     Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00142.
     PubMed     Abstract available
     
     
     
276. NOURAEI H, Rabkin SW
     A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
     Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
     PubMed     Abstract available
     
     
     
277. THEUNS DAMJ, Schaer BA, Caliskan K, Hoeks SE, et al
     Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization defibrillators.
     Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00091.
     PubMed     Abstract available
     
     
     
278. SABOUR S, Ghajari H
     Risk prediction models for heart failure admissions in adults with congenital heart disease: Methodological issues.
     Int J Cardiol. 2021 Jan 25. pii: S0167-5273(21)00083.
     PubMed    
     
     
     
279. CAMELI M, Pastore MC, Mandoli GE
     Left atrial strain: A key element for the evaluation of patients with HFpEF.
     Int J Cardiol. 2021;323:197-198.
     PubMed    
     
     
     
280. SAVIRA F, Edgley AJ, Jucker BM, Willette RN, et al
     RE: Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome.
     Int J Cardiol. 2021;323:260.
     PubMed    
     
     
     
281. WEI WY, Lian ZX, Ji Y, Zhang N, et al
     Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis.
     Int J Cardiol. 2021;323:205.
     PubMed    
     
     
     
282. DANI SS, Ganatra S, Vaduganathan M
     Angioedema with sacubitril/valsartan: Trial-level meta-analysis of over 14,000 patients and real-world evidence to date.
     Int J Cardiol. 2021;323:188-191.
     PubMed     Abstract available
     
     
     
283. IZUMIDA T, Imamura T
     Clinical significance of B-type natriuretic peptide in patient with acute decompensated heart failure.
     Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34326.
     PubMed    
     
     
     
284. GALLO-BERNAL S, Calixto CA, Molano-Gonzalez N, Moreno MPD, et al
     Impact of a pharmacist-based multidimensional intervention aimed at decreasing the risk of hyperkalemia in heart failure patients: A Latin-American experience.
     Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34329.
     PubMed     Abstract available
     
     
     
285. KUMAR V, Ryu AJ, Manduca A, Rao C, et al
     Cardiac MRI demonstrates compressibility in healthy myocardium but not in myocardium with reduced ejection fraction.
     Int J Cardiol. 2021;322:278-283.
     PubMed     Abstract available
     
     
     
286. RYU AJ, Kumar V, Borlaug BA, Manduca A, et al
     Systolic-to-diastolic myocardial volume ratio as a novel imaging marker of cardiomyopathy.
     Int J Cardiol. 2021;322:272-277.
     PubMed     Abstract available
     
     
     December 2020
287. KAWADA T
     Risk of heart failure and prognosis in patients with atrial fibrillation.
     Int J Cardiol. 2020 Dec 31. pii: S0167-5273(20)34316.
     PubMed    
     
     
     
288. IMAMURA T
     Therapeutic strategy for the patients with Takayasu arteritis and heart failure.
     Int J Cardiol. 2020 Dec 31. pii: S0167-5273(20)34318.
     PubMed    
     
     
     
289. MAGGIONI AP
     How to appropriately update practicing clinicians on innovations in heart failure therapy waiting for the new version of the guidelines?
     Int J Cardiol. 2020 Dec 24. pii: S0167-5273(20)34290.
     PubMed    
     
     
     
290. PESTELLI G, Fiorencis A, Trevisan F, Luisi GA, et al
     New measures of right ventricle-pulmonary artery coupling in heart failure: An all-cause mortality echocardiographic study.
     Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34305.
     PubMed     Abstract available
     
     
     
291. AGARWAL A, Mohanan PP, Kondal D, Baldridge A, et al
     Effect of a quality improvement intervention for acute heart failure in South India: An interrupted time series study.
     Int J Cardiol. 2020 Dec 21. pii: S0167-5273(20)34296.
     PubMed     Abstract available
     
     
     
292. GAU SY
     Confusing heart failure ischemic etiology prevalence trend and the definition of composite events.
     Int J Cardiol. 2020 Dec 14. pii: S0167-5273(20)34276.
     PubMed    
     
     
     
293. KWOK CS, Abramov D, Parwani P, Ghosh RK, et al
     Cost of inpatient heart failure care and 30-day readmissions in the United States.
     Int J Cardiol. 2020 Dec 12. pii: S0167-5273(20)34268.
     PubMed     Abstract available
     
     
     
294. TAKAHAMA H, Izumi C
     Palliative care for patients with advanced heart failure: When is the optimal timing of advanced care planning?
     Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34251.
     PubMed    
     
     
     
295. VOLPE M, Bauersachs J, Bayes-Genis A, Butler J, et al
     Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence.
     Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34242.
     PubMed     Abstract available
     
     
     
296. SAKANE K, Kanzaki Y, Tsuda K, Maeda D, et al
     Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction.
     Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34235.
     PubMed     Abstract available
     
     
     
297. CHIONCEL O, Ambrosy AP
     Improving adherence to guideline-directed medical therapies and outcomes in the developing world: A call to end global inequities in heart failure.
     Int J Cardiol. 2020 Dec 2. pii: S0167-5273(20)34230.
     PubMed    
     
     
     
298. PAN J, Wang L, Sun Y
     Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome.
     Int J Cardiol. 2020;320:139.
     PubMed    
     
     
     November 2020
299. FERNANDEZ-MARTINEZ J, Romero-Correa M, Salamanca-Bautista P, Aramburu-Bodas O, et al
     Prevalence of advanced heart failure and use of palliative care in admitted patients: Findings from the EPICTER study.
     Int J Cardiol. 2020 Nov 7. pii: S0167-5273(20)34076.
     PubMed     Abstract available
     
     
     
300. WANG Y, Tse G, Roever L, Liu T, et al
     Sacubitril/valsartan in the treatment of cancer therapy-related cardiac dysfunction.
     Int J Cardiol. 2020;318:130.
     PubMed    
     
     
     October 2020
301. SCHWARTZ B, Schou M, Gislason GH, Kober L, et al
     Prevalence and incidence of various cancer subtypes in patients with heart failure vs matched controls.
     Int J Cardiol. 2020 Oct 31. pii: S0167-5273(20)34065.
     PubMed    
     
     
     
302. PUGLIESE NR, Rosada J, Masi S
     Train the brain to preserve the heart: the link between education and heart failure.
     Int J Cardiol. 2020 Oct 30. pii: S0167-5273(20)34057.
     PubMed    
     
     
     
303. RAVAL AN, Johnston PV, Duckers HJ, Cook TD, et al
     Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
     Int J Cardiol. 2020 Oct 19. pii: S0167-5273(20)33996.
     PubMed     Abstract available
     
     
     
304. ZHANG Y, Fan P, Zhang H, Ma W, et al
     Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients.
     Int J Cardiol. 2020 Oct 18. pii: S0167-5273(20)33984.
     PubMed     Abstract available
     
     
     
305. HARIKRISHNAN S, Jeemon P, Ganapathi S, Agarwal A, et al
     Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registry.
     Int J Cardiol. 2020 Oct 10. pii: S0167-5273(20)33921.
     PubMed     Abstract available
     
     
     
306. LEE SY, Kim HL, Kim MA, Park JJ, et al
     Obesity paradox in Korean male and female patients with heart failure: A report from the Korean heart failure registry.
     Int J Cardiol. 2020 Oct 9. pii: S0167-5273(20)33922.
     PubMed     Abstract available
     
     
     
307. SHARMA K, Premchand RK, Mittal S, Monteiro R, et al
     Long-term follow-up of patients with heart failure and reduced ejection receiving autonomic regulation therapy in the ANTHEM-HF pilot study.
     Int J Cardiol. 2020 Oct 7. pii: S0167-5273(20)33902.
     PubMed     Abstract available
     
     
     
308. PANA TA, Mohamed MO, Clark AB, Fahy E, et al
     Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure.
     Int J Cardiol. 2020 Oct 3. pii: S0167-5273(20)33906.
     PubMed     Abstract available
     
     
     
309. LIAO LZ, Zhuang XD, Zhang SZ, Liao XX, et al
     Education and heart failure: New insights from the atherosclerosis risk in communities study and mendelian randomization study.
     Int J Cardiol. 2020 Oct 2. pii: S0167-5273(20)33898.
     PubMed     Abstract available
     
     
     
310. ZHONG P, Yuan M, Kong B, Huang H, et al
     ASK-1, a new target in treating cardiorenal syndrome (CRS).
     Int J Cardiol. 2020;316:208.
     PubMed    
     
     
     
311. SAVIRA F, Kompa AR, Edgley AJ, Jucker BM, et al
     RE: ASK1, a new target in treating cardiorenal syndrome (CRS).
     Int J Cardiol. 2020;316:207.
     PubMed    
     
     
     September 2020
312. SHIBATA N, Kondo T, Kazama S, Kimura Y, et al
     Impact of predictive value of Fibrosis-4 index in patients hospitalized for acute heart failure.
     Int J Cardiol. 2020 Sep 29. pii: S0167-5273(20)33837.
     PubMed     Abstract available
     
     
     
313. SURKOVA E, Segura T, Dimopouosl K, Bispo D, et al
     Systolic dysfunction of the subpulmonary left ventricle is associated with the severity of heart failure in patients with a systemic right ventricle.
     Int J Cardiol. 2020 Sep 25. pii: S0167-5273(20)33832.
     PubMed     Abstract available
     
     
     
314. AMMIRATI E, Brambatti M, Braun OO, Shah P, et al
     Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device: Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA).
     Int J Cardiol. 2020 Sep 17. pii: S0167-5273(20)33807.
     PubMed     Abstract available
     
     
     
315. BRIDA M
     Heart transplantation in adult congenital heart disease: Importance of timely referral.
     Int J Cardiol. 2020 Sep 14. pii: S0167-5273(20)33822.
     PubMed    
     
     
     August 2020
316. MERAS P, Riesgo-Gil F, Rybicka J, Barradas-Pires A, et al
     Heart transplantation at a single tertiary adult congenital heart disease centre: Too little, too late?
     Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33574.
     PubMed     Abstract available
     
     
     
317. SANDERSON JE, Fang F
     Cardiac cycle time intervals are back again.
     Int J Cardiol. 2020;312:87-88.
     PubMed    
     
     
     July 2020
318. ALKHALIL M, Kearney A, MacElhatton D, Fergie R, et al
     The prognostic role of mid-range ejection fraction in ST-segment elevation myocardial infarction.
     Int J Cardiol. 2020 Jul 15. pii: S0167-5273(20)33449.
     PubMed     Abstract available
     
     
     April 2020
319. LEE EC, McNitt S, Martens J, Bruckel JT, et al
     Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure.
     Int J Cardiol. 2020 Apr 19. pii: S0167-5273(19)34902.
     PubMed     Abstract available
     
     
     March 2020
320. GAVAZZONI M, Taramasso M, Zuber M, Pozzoli A, et al
     Functional mitral regurgitation and cardiac resynchronization therapy in the "era" of trans-catheter interventions: Is it time to move from a staged strategy to a tailored therapy?
     Int J Cardiol. 2020 Mar 28. pii: S0167-5273(19)35293.
     PubMed     Abstract available
     
     
     February 2020
321. RASHID M, Curzen N, Kinnaird T, Lawson CA, et al
     Baseline risk, timing of invasive strategy and guideline compliance in NSTEMI: Nationwide analysis from MINAP.
     Int J Cardiol. 2020;301:7-13.
     PubMed     Abstract available
     
     
     
322. LAHUERTA C, Menao S, Gracia-Gutierrez A, Bueno-Juana E, et al
     Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting.
     Int J Cardiol. 2020;301:220-225.
     PubMed     Abstract available
     
     
     
323. CAZZOLI I, Gunturiz-Beltran C, Guarguagli S, Alonso-Gonzalez R, et al
     Catheter ablation for patients with end-stage complex congenital heart disease or cardiomyopathy considered for transplantation: Trials and tribulations.
     Int J Cardiol. 2020;301:127-134.
     PubMed     Abstract available
     
     
     January 2020
324. SPEE RF, Niemeijer VM, Schoots T, Tuinenburg A, et al
     High intensity interval training after cardiac resynchronization therapy: An explorative randomized controlled trial.
     Int J Cardiol. 2020;299:169-174.
     PubMed     Abstract available
     
     
     December 2019
325. GRAMEGNA M, Beneduce A, Bertoldi LF, Pagnesi M, et al
     Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization.
     Int J Cardiol. 2019 Dec 13. pii: S0167-5273(19)35516.
     PubMed     Abstract available
     
     
     October 2019
326. GARCIA R, Boveda S, Defaye P, Sadoul N, et al
     Early mortality after implantable cardioverter defibrillator: Incidence and associated factors.
     Int J Cardiol. 2019 Oct 30. pii: S0167-5273(19)33062.
     PubMed     Abstract available
     
     
     June 2019
327. BACKHAUS SJ, Kowallick JT, Stiermaier T, Lange T, et al
     Atrioventricular mechanical coupling and major adverse cardiac events in female patients following acute ST elevation myocardial infarction.
     Int J Cardiol. 2019 Jun 16. pii: S0167-5273(19)30773.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: